India's JB Pharma's Q2 profit rises on higher domestic demand
Nov 6 (Reuters) -India's J B Chemicals & Pharmaceuticals JBCH.NS reported a rise in second-quarter profit on Wednesday, helped by higher domestic demand for its gastrointestinal and cardiovascular drugs.
The drugmaker's consolidated net profit rose 16% to 1.75 billion rupees (about $20.8 million) for the quarter ended Sept. 30.
Its revenue climbed 13.5% to 10.01 billion rupees, with the domestic formulations business – which forms about 60% of total revenue – rising 22%.
For further earnings highlights, click nFWN3MD0U1
KEY CONTEXT
The company continued to benefit from buoyant demand for its copycat drugs such as antibiotic Metrogyl, which treats infections of the liver and stomach,and lozenges for sore throats.
Analysts noted that drugmakers would benefit from domestic demand in the quarter, as heavy rains would likely result in the spread of water-borne diseases.
A recovery in demand in J B Pharma's key South Africa market also aided its earnings, the company said.
Larger peers Cipla CIPL.NS and Sun Pharma SUN.NS beat second-quarter profit estimates on the back of resilient sales in India and the U.S., a key market for these companies.
PEER COMPARISON
Estimates (next 12 months) | Analysts' sentiment | ||||||||
RIC | PE | EV/EBITDA | Revenue growth (%) | Profit growth (%) | Mean rating* | # of analysts | Stock to price target** | Div yield (%) | |
J B Chemicals and Pharmaceuticals Ltd | JBCH.NS | 37.19 | 24.22 | 13.68 | 22.13 | Buy | 11 | 0.95 | 0.66 |
Cipla Ltd | CIPL.NS | 25.90 | 16.39 | 8.14 | 9.84 | Hold | 33 | 0.97 | 0.81 |
Sun Pharmaceutical Industries Ltd | SUN.NS | 35.29 | 26.01 | 9.73 | 14.75 | Buy | 32 | 0.93 | 0.75 |
Dr Reddy's Laboratories Ltd | REDY.NS | 18.07 | 11.86 | 9.29 | 3.51 | Hold | 34 | 0.97 | 0.63 |
JULY-SEPTEMBER STOCK PERFORMANCE
($1 = 84.2940 Indian rupees)
JB Pharma v Peers https://tmsnrt.rs/3YV6Pra
Reporting by Nandan Mandayam in Bengaluru; Editing by Varun H K
Eng oxirgi yangiliklar
Javobgarlikdan voz kechish: XM Group korxonalari har biri faqat ijro xizmatlarini koʻrsatadi va onlayn savdo platformamizdan foydalanish huquqini beradi, bu odamga veb-saytda yoki veb-sayt orqali mavjud boʻlgan kontentni koʻrish va/yoki undan foydalanishga ruxsat beradi hamda uni oʻzgartirishga moʻljallanmagan va uni oʻzgartirmaydi yoki kengaytirmaydi. Bunday kirish va foydalanish huquqi doimo quyidagilarga boʻysunadi: (i) Shartlar va qoidalar; (ii) Risklar haqida ogohlantirish; va (iii) Javobgarlikni toʻliq rad etish. Shuning uchun bunday kontent umumiy maʼlumot sifatida taqdim etiladi. Xususan, shuni esda tutingki, bizning onlayn savdo platformamiz mazmuni moliyaviy bozorlarda biror bitimni amalga oshirishga oid maslahat yoki taklif emas. Har qanday moliyaviy bozorda savdo qilish sizning kapitalingiz uchun jiddiy risk darajasini oʻz ichiga oladi.
Onlayn savdo platformamizda chop etilgan barcha materiallar faqat taʼlim/axborot maqsadlari uchun moʻljallangan va unda moliyaviy, investitsiya soligʻi yoki savdo maslahatlari va tavsiyalar; yoki bizning savdo narxlarimizning qaydlari; yoki har qanday moliyaviy vositalar bilan bitim tuzish maslahati yoki taklifi; yoki sizga kerak boʻlmagan moliyaviy reklama aksiyalari hisoblanmaydi
Har qanday uchinchi tomon kontenti, shuningdek XM tomonidan tayyorlangan kontent, masalan: fikrlar, yangiliklar, tadqiqotlar, tahlillar, narxlar va boshqa maʼlumotlar yoki bu veb-saytda joylashgan uchinchi tomon saytlariga havolalar umumiy bozor sharhi sifatida "boricha" taqdim etiladi va investitsiya maslahatini tashkil etmaydi. Har qanday kontent investitsiya tadqiqoti sifatida talqin qilinsa, siz bunday kontentni investitsiya tadqiqotlarining mustaqilligini ragʻbatlantirish uchun moʻljallangan qonun talablariga muvofiq moʻljallanmagan va tayyorlanmaganligini eʼtiborga olishingiz va qabul qilishingiz kerak, shuning uchun unga tegishli qonunlar va qoidalarga muvofiq marketing kommunikatsiyasi sifatida qaraladi. Mustaqil boʻlmagan investitsiya tadqiqoti va yuqoridagi maʼlumotlarga oid risk haqida ogohlantirishimizni oʻqib chiqqaningizga va tushunganingizga ishonch hosil qiling, unga bu yerdan kirish mumkin.
